0.4206

4.88% -0.0216

Verrica Pharmaceuticals Inc (VRCA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.4422

Aprire:

$0.44

Volume 24 ore:

363.10K

Relative Volume:

0.88

Capitalizzazione di mercato:

$38.60M

Reddito:

$5.12M

Utile/perdita netta:

$-67.00M

Rapporto P/E:

-0.2861

EPS:

-1.47

Flusso di cassa netto:

$-38.94M

1 W Prestazione:

-11.77%

1M Prestazione:

-35.20%

6M Prestazione:

-69.30%

1 anno Prestazione:

-92.90%

Intervallo 1D:

$0.3995

$0.44

Intervallo di 1 settimana:

$0.3861

$0.4929

Portata 52W:

$0.3861

$11.41

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Nome

Verrica Pharmaceuticals Inc

Settore

Healthcare (1165)

Industria

Biotechnology (681)

Telefono

484-453-3300

Indirizzo

10 NORTH HIGH STREET, WEST CHESTER, PA

Dipendente

Cinguettio

Prossima data di guadagno

2025-03-11

Ultimi documenti SEC

VRCA's Discussions on Twitter

Confronta VRCA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VRCA Verrica Pharmaceuticals Inc	0.4206	38.60M	5.12M	-67.00M	-38.94M	-1.47
VRTX Vertex Pharmaceuticals Inc	484.74	124.48B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	617.00	67.45B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	567.09	34.59B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	255.76	33.10B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	271.04	29.15B	3.81B	-644.79M	-669.77M	-6.24

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-06	Downgrade	H.C. Wainwright	Buy → Neutral
2024-11-05	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2023-07-25	Aggiornamento	Needham	Hold → Buy
2023-03-22	Iniziato	Jefferies	Buy
2023-02-13	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2022-05-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2021-05-14	Iniziato	RBC Capital Mkts	Outperform
2020-12-24	Reiterato	H.C. Wainwright	Buy
2020-07-15	Downgrade	BofA Securities	Buy → Neutral
2020-06-30	Reiterato	H.C. Wainwright	Buy
2020-06-24	Iniziato	Northland Capital	Outperform
2020-03-24	Iniziato	Needham	Buy
2019-02-21	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Verrica Pharmaceuticals Inc Borsa (VRCA) Ultime notizie

02:00 AM

Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MyChesCo

02:00 AM

Apr 01, 2025

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now - MSN

Apr 01, 2025

Harmony, Lungpacer, Verrica and Arbutus make C-suite hires - The Business Journals

Apr 01, 2025

Mar 31, 2025

Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 31, 2025

Exclusive: Verrica Pharmaceuticals CEO Fireside Chat at Major Healthcare Conference - Stock Titan

Mar 31, 2025

Mar 30, 2025

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer - MSN

Mar 30, 2025

Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments By Investing.com - Investing.com South Africa

Mar 26, 2025

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer - GlobeNewswire

Mar 26, 2025

Verrica Pharmaceuticals appoints Rosenberg as CMO - MSN

Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments - Investing.com

Mar 26, 2025

Dermatology Drug Pioneer Joins Verrica to Accelerate YCANTH Growth - Stock Titan

Mar 26, 2025

Mar 19, 2025